The Biologics News and Reports Portal

Show Cart

All Products

Results 181 - 192 of 192

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

2,495.00 €

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

2,450.00 €

Apr 2009 Competitor Analysis: Hypoxia-Inducible Factor (HIF)

100.00 €

Sep 2008 Competitor Analysis: HDL Raising Therapies

250.00 €

Oct 2005 R&D Pipeline News - Technology Edition: 1-Yr Subscription

900.00 €

Oct 2005 R&D Pipeline News - Therapeutic Area Edition: 1-Yr Subscription

900.00 €

Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End

Shopping cart

Cart empty

Latest report

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective

Featured Products

Report bundle: Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Latest Target Pipeline

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Shopping cart

Cart empty

Latest report

Featured Products

Report bundle: Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Latest Target Pipeline

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

All Products

Jun 2011 Competitor Analysis: Hepatitis Vaccines

May 2011 Competitor Analysis: Influenza Vaccines

Apr 2011 Competitor Analysis: Targeted Therapy of Diabetes

Apr 2011 Competitor Analysis: Emerging Diabetes Drugs

Mar 2011 Competitor Analysis: Targeted Therapy of Obesity

Nov 2010 Antibody Technology Companies 2010

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

Apr 2009 Competitor Analysis: Hypoxia-Inducible Factor (HIF)

Sep 2008 Competitor Analysis: HDL Raising Therapies

Oct 2005 R&D Pipeline News - Technology Edition: 1-Yr Subscription

Oct 2005 R&D Pipeline News - Therapeutic Area Edition: 1-Yr Subscription

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing